These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1478 related articles for article (PubMed ID: 28476146)

  • 41. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).
    Fu M; Ahrenmark U; Berglund S; Lindholm CJ; Lehto A; Broberg AM; Tasevska-Dinevska G; Wikstrom G; Ågard A; Andersson B;
    Clin Res Cardiol; 2017 Dec; 106(12):960-973. PubMed ID: 28795299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF.
    Tebbe U; Tschöpe C; Wirtz JH; Lokies J; Turgonyi E; Bramlage P; Strunz AM; Lins K; Böhm M
    Clin Res Cardiol; 2014 Aug; 103(8):665-73. PubMed ID: 24535376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
    J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline Adherence.
    Sung SH; Wang TJ; Cheng HM; Yu WC; Guo CY; Chiang CE; Chen CH
    Sci Rep; 2018 Sep; 8(1):14270. PubMed ID: 30250052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outpatient management of heart failure in the United States, 2006-2008.
    Mosalpuria K; Agarwal SK; Yaemsiri S; Pierre-Louis B; Saba S; Alvarez R; Russell SD
    Tex Heart Inst J; 2014 Jun; 41(3):253-61. PubMed ID: 24955039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study.
    Sepehrvand N; Nabipoor M; Youngson E; McAlister FA; Ezekowitz JA
    J Card Fail; 2023 May; 29(5):719-729. PubMed ID: 36754252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adherence to guidelines in CHF therapy in Germany].
    Flesch M; Komajda M; Lapuerta P; Hermans N; Le Pen C; Gonzáles-Juanatey JR; Van Veldhuisen DJ; Tavazzi L; Poole-Wilson P; Erdmann E
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2191-7. PubMed ID: 16189755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A strategy to improve adherence to guideline-directed medical therapy (GDMT) and the role of the multidisciplinary team in a heart-failure programme.
    AlHabeeb W; Alayoubi F; Hayajneh A; Ullah A; Elshaer F
    Cardiovasc J Afr; 2024 Jan-Apr 23; 35(1):12-15. PubMed ID: 37171293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart failure guidelines: What's new?
    Papadimitriou L; Hamo CE; Butler J
    Trends Cardiovasc Med; 2017 Jul; 27(5):316-323. PubMed ID: 28185709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany.
    Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T
    Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure.
    Veenis JF; Brunner-La Rocca HP; Linssen GCM; Van Gent MWF; Hoes AW; Brugts JJ;
    Circ Heart Fail; 2020 May; 13(5):e006667. PubMed ID: 32370547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study.
    Durstenfeld MS; Katz SD; Park H; Blecker S
    BMC Cardiovasc Disord; 2019 Aug; 19(1):194. PubMed ID: 31399059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.
    Stark R; Kirchberger I; Hunger M; Heier M; Leidl R; von Scheidt W; Meisinger C; Holle R
    Clin Res Cardiol; 2014 Mar; 103(3):237-45. PubMed ID: 24287605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction.
    Chen X; Cui X; Thunström E; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2021 Jul; 110(7):1051-1062. PubMed ID: 33394127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
    Chang TE; Park S; Yang Q; Loustalot F; Butler J; Ritchey MD
    PLoS One; 2019; 14(9):e0222868. PubMed ID: 31545830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A
    J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.